REFERENCES
1. Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS Guidelines
for the man Agement of valvular heart disease. Eur Heart J . 2017;
38: 2739-2791.
2. Lung B, Baron G, Tornos P, et al. Valvular heart disease in
the community: a Eu Ropean experience. Curr Probl Cardiol . 2007;
32: 609-661.
3. Galloway AC, Grossi EA et al. Operative therapy for mitral
insufficiency from coronary artery disease. Semin. Thorac.Cardiovasc. Surg . 1995; 7:227-232.
4. Praet KMV, Stamm C, Sündermann SH, et al. Minimally invasive
surgical mitral valve repair: state of the art review. Interv
Cardiol . 2018; 13: 14-19.
5. Bonow RO, Carabello BA, Kanu C, de LA, Jr, Faxon DP, Freed
MD, et al. ACC/AHA 2006 guidelines for the management of patients with
valvular heart disease: a report of the American College of
Cardiology/American Heart Association Task Force on Practice Guidelines
(writing committee to revise the 1998 Guidelines for the Management of
Patients With Valvular Heart Disease): developed in collaboration with
the Society of Cardiovascular Anesthesiologists: endorsed by the Society
for Cardiovascular Angio graphy and Interventions and the Society of
Thoracic Surgeons. Circulation 2006;114:e84-231. repair and
revascularization for ischemic mitral regurgitation: predictors of
operative mortality and survival. J Heart Valve Dis 2002;
11:793-800.
6. Akar AR, Doukas G, Szafranek A, Alexiou C, Boehm MC, Chin D,
et al. Mitral valve 2005;28:361-362.
7. Akar AR, Ozyurda U. Surgery for ischemic mitral valve
prolapse. Eur J Cardiothorac Surg 2005;28:361-362.
8. American Heart Association Heart Facts. Dallas American
Heart Association National C.P1,1990.
9 . David TE. Techniques and results of mitral valve repair for
ischemic mitral regurgitation. J Card Surg . 1994; 9 (23):
274-281.
10. Hendren WG, Nemec JJ, Lytle BW et al. Mitral valve repair
for ischemic mitral insufficiency. Ann Thorac Surg .
1991;52:1246-51.
11. Bulkley BH, Roberts WC. Dilatation of the mitral annulus. A
rare cause of mitral regurgitation. Am J Med. 1975;59:457.
12. Oury JH, Cleveland JC, Duran CG, Angell WW. Ischemic mitral
valve disease; Classification and systemic approach to management.J Card Surg . 1995;9(Suppl):262-73.
13. David TE. Techniques and results of mitral valve repair for
ischemic mitral regurgitation. J Card Surg. 1994; 9 (Suppl 23):
274-281.
14. Akins CW, Hilgenberg AD, Buckley MJ et al. Mitral valve
reconstruction versus replacement for degenerative or ischemic mitral
regurgitation. Ann Thorac Surg . 1994; 58: 668-676.
15 . Zanaboni G, Dyne KM, Rossi A, et al. Prolidase deficiency:
biochemical study of erythrocyte and skin fibroblast prolidase activity
in Italian patients. Haematologica. 1994; 79:13-18.
16 . Palka JA, Phang JM. Prolidase activity in fibroblasts is
regulated by interaction of extracellular matrix with cell surface
integrin receptors. J Cell Biochem. 1997; 67:166-175.
17. McRae PA, Porter BE. The perineuronal net component of the
extracellular matrix in plasticity and epilepsy. Neurochem Int.2012; 61: 963-972.
18. Hauptmann M, Wilson DF, Erecinska M. High affinity proline
uptake in rat brain synaptosomes. FEBS Lett . 1983;161:301-305.
19. Crump FT, Fremeau RT, Craig AM. Localization of the
brain-specific high-affinity Iproline transporter in cultured
hippocampal neurons:molecular heterogeneity of synaptic terminals.Mol Cell Neurosci. 1999; 13:25- 39.
20. Horoz M, Aslan M, Bolukbas FF, et al. Serum prolidase
enzyme activity and its relation to histopathological findings in
patients with nonalcoholic steatohepatitis. J Clin Lab Anal.2010; 24:207-211.
21. Rabus M, Demirbag R, Sezen Y, et al. Plasma and tissue
oxidative stress index in patients with rheumatic and degenerative heart
valve disease. Turk Kardiyol Dern Ars. 2008; 36:536-540.
22. Yıldız B, Demirbağ R, Yılmaz R, Gür M, Altıparmak IH, Akyol
S, Aksoy N, Ocak AR, Erel O. The association of serum prolidase activity
with the presence and severity of coronary artery disease.Coron Artery Dis. 2008
Aug;19(5):319-25. doi: 10.1097/MCA.0b013e32830042ba.
23. Gillinov AM, Wierup PN, Blackstone EH, Bis-hay ES, Cosgrove
DM, White J, Lytle BW, McCarthy PM. Is repair preferable to replacement
for ischemic mitral regurgitation? J Thorac Cardiovasc Surg.2001;122:1125-41.
24. Demirbağ R, Yıldız A, Gur M, Yilmaz R, Elçi K, Aksoy N.
Serum prolidase activity in patients with hypertension and itsrelation
with left ventricular hypertrophy. Clinical Biochemistry . 2007;
(40): 1020–1025.
25. Koçarslan A, Koçarslan S, Aydın M.S, Altıparmak İ.H, Demir
D, Sezen H, Yüce H.H, Göz M. Archives of Medical Research. 2016;
(47): 200-206.
26. Rabus M, Demirbag R, Sezen Y, et al. Plasma and tissue
oxidative stress index in patients with rheumatic and degenerative heart
valve disease. Turk Kardiyol Dern Ars. 2008;36:536 - 540.
27. Yildiz A, Demirbag R, Yilmaz R, et al. The association of
serum prolidase activity with the presence and severity of coronary
artery disease. Coron Artery Dis. 2008;19:319 - 325.